Merck-Pfizer Avelumab on FDA Fast Track

08.10.2015 - After previously receiving Orphan Drug status for avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody to treat the rare and aggressive skin cancer Merkel...